Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia
|
|
- Elwin Fleming
- 5 years ago
- Views:
Transcription
1 Patient Experience Research in Malignant Hematology: describing the lived experience of illness with acute myeloid leukemia Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division of Hematologic Malignancies Director, Cancer Patient Experience Research Program (CPEP)
2 Outline Thought exercise epro data Quality and outcomes data in hematologic malignancies Novel interventions to address unmet needs 2
3 3
4 7
5 Your Choices Intensive induction chemotherapy Low-dose chemotherapy Clinical trial Supportive care Hospice care 8
6
7 MATRIX BLUE PILL RED PILL PIC 10
8 Markedly different risk Induction chemo = 30 days in the hospital Profound neutropenia for > 1 week Risk of invasive fungal infections, severe bacterial sepsis 2-5% risk of death from treatment Must be followed by several rounds of consolidation chemotherapy in order to cure Most patients are in and out of the hospital, develop various infections, and require intermittent transfusions Usually a 4-6 month process altogether 11
9 Outcomes age 60+ Wheatley, et al, BJH
10 Juxtaposition Remission rates with initial induction chemo are 50-85%, depending on the situation this improves longevity and QoL, even if relapse is expected later Some patients are definitively CURED with these intensive regimens, especially those under age 60 The upfront focus on cure is often very appropriate 13
11 Long-term Survival age < 60 Schlenk RF, et al. N Engl J Med 2008;358:
12 What s Missing from the Story Patient issues: What s the patient experience like? How does it differ across the major treatment paradigms? What happens when it doesn t go well? What are their palliative care needs? Clinician issues: Why aren t more being referred to palliative care? What do the doctors think about palliative care? 15
13 Our Study Longitudinal, observational, mixed-methods approach Subjects: AML patients starting a new course of inpatient chemotherapy Setting: inpatient hematologic malignancies ward, Duke University Hospital Measures: 1. Electronic patient-reported outcomes (epros) Weekly while hospitalized; monthly thereafter 2. Semi-structured qualitative interviews At baseline, then quarterly thereafter 16
14 Assessments Symptoms by the Patient Care Monitor (PCM) v2.0 Validated 80-item (86 in women) review of systems assessment tool QoL by the FACT-Leu 27 items in FACT-G, across 4 QoL domains (emotional, physical, social, functional); +17 items in leukemia scale Distress by the NCCN Distress Thermometer Single question, 0 to 10 point scale associated questions about which issues are contributing to the distress (yes/no) 17
15 epro Symptom Assessments PCM
16 epro Distress Thermometer 19
17 de novo AML (N = 19) Secondary/Relapsed AML (N = 23) Total (N = 42) Age Mean (SD) 62.1 (14.3) 56.8 (12.5) 59.2 (13.5) Female, n (%) 9 (47.4) 11 (47.8) 20 (47.6) Marital status, n (%) Married 12 (63.2) 17 (73.9) 29 (69.0) Divorced 2 (10.5) 3 (13.0) 5 (11.9) Single 1 (5.3) 3 (13.0) 4 (9.5) Widowed 4 (21.1) 0 (0.0) 4 (9.5) Highest level of education completed, n (%) High school diploma or 8 (42.1) 6 (26.1) 14 (33.3) equivalent Some college 3 (15.8) 4 (17.4) 7 (16.7) Vocational-technical degree 2 (10.5) 1 (4.3) 3 (7.1) Associate s degree 1 (5.3) 6 (26.1) 7 (16.7) Bachelor s degree 1 (5.3) 3 (13.0) 4 (9.5) Graduate degree 4 (21.1) 3 (13.0) 7 (16.7) Race, n (%) Caucasian/white 18 (94.7) 19 (82.6) 37 (88.1) Black or African American 0 (0.0) 2 (8.7) 2 (4.8) American Indian/Alaska 0 (0.0) 1 (4.3) 1 (2.4) native Asian 1 (5.3) 0 (0.0) 1 (2.4) More than one race 0 (0.0) 1 (4.3) 1 (2.4) Ethnicity, n (%) Not Hispanic or Latino 19 (100.0) 23 (100.0) 42 (100.0) If relapsed, what is the number of prior treatment No relapse 19 (100.0) 13 (56.5) 32 (76.2) 1 0 (0.0) 1 (4.3) 1 (2.4) 2 0 (0.0) 5 (21.7) 5 (11.9) 3 or more 0 (0.0) 4 (17.4) 4 (9.5) Risk, n (%) Favorable risk 7 (36.8) 1 (4.3) 8 (19.0) Intermediate risk 2 (10.5) 6 (26.1) 8 (19.0) Adverse risk 10 (52.6) 16 (69.6) 26 (61.9)
18
19
20 Prevalent Moderate/Severe Symptoms Symptom Frequency Fatigue 48-83% Diarrhea 59-64% (weeks 2-3) Insomnia 32-44% Dry mouth 35-50% Fever 30-48% (weeks 2-4) Nausea 30-43% (vomiting <<10%) Pain 32-35% (weeks 2-3) Helplessness 18-26% Sadness/depression 17-26% 23
21
22
23
24
25
26 Kayastha N, et al. Supp Care Cancer,
27 Kayastha N, et al. Supp Care Cancer,
28 Kayastha N, et al. Supp Care Cancer,
29 Typical Assumptions 1. Treatment-induced symptoms will improve in a few weeks regardless, so time is the best medicine 2. Oncologists already do a good job of managing acute treatment-related symptoms 3. Achieving remission is associated with feeling better overall 32
30 Challenging Assumptions These findings suggest that: 1. There are several distinct, treatable symptoms that occur predictably during induction 2. Symptoms are not all resolved by the 4 th week 3. Standard-of-care approaches leave patients with persistent symptoms during induction 4. Patients w/relapsed disease, or secondary/therapy-related AML do much worse 33
31 Targets for Intervention Feasible targets for intervention include: Diarrhea (weeks 2 and 3) Insomnia, throughout hospitalization Nausea throughout Dry mouth (and mouth sores) in weeks 2-4 Physical pain in weeks 2 and 3 Mood/distress 34
32 WHAT ACTUALLY HAPPENS 35
33 54% 36
34 81% 37
35 39% 38
36 43% 39
37 11 40
38 57,230 40,610 41
39 Unmet End-of-Life Needs in Hematologic Malignancies 81% Solid tumors Heme-malignancy Solid tumors All p-values < % 43% 47% 47% 39% 43% 33% 16% 14% 8% 4% ER visits Hospital admission Hospital death ICU admission ICU death chemo use Hui, et al. Cancer 2014
40 Outcomes: The Quality Measures Gap Patients with blood cancers are more likely to: 1,2 receive chemotherapy in the last 14 days of life spend time in an ICU in the last 30 days of life Patients with blood cancers are less likely to: access consultative palliative care services 3 use hospice services 4 Or, are more likely to die within 7 days of enrollment, or within 24 hrs of enrollment 5 Median LOS of 11 days, vs. 19 for solid tumors 5 1. Howell, DA, et al. Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Pall Care, Hui, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer Howell DA, et al. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med Odejide, et al. Hospice use among patients with lymphoma: impact of disease aggressiveness and curability. JNCI, LeBlanc TW, Abernethy AP, Casarett DJ. What Is Different About Patients With Hematologic Malignancies? A Retrospective Cohort Study of Cancer Patients Referred to a Hospice Research Network. Journal of Pain and Symptom Management,
41 44
42 What the literature tells us 1. Unique barriers to EOL care 2. Clinicians are different 3. Hospice doesn t work well in hematology 45
43 Blood Cancers are Different Remarkable prognostic heterogeneity (uncertainty) Some entirely curable with chemotherapy Others more like chronic, indolent diseases; More likely to die of something else Some confer a dismal prognosis, yet cure remains possible When curative-intent treatments do not work, much misery may result Sometimes almost kill to cure LeBlanc TW, JOP
44 Unique Barriers to EOL Care Identifying the end-of-life phase is more difficult 1 Survey data on heme docs perspectives about barriers to EOL care: 2 Unrealistic patient expectations (97.3%) Clinician concern about taking away hope (71.3%) Unrealistic clinician expectations (59%) 1. Odejide O, et al. End-of-life care for patients with blood cancers: a series of focus groups with hematologic oncologists. JOP Odejide O, et al. Barriers to quality end-of-life care for patients with blood cancers. JCO,
45 The Doctors are Different Survey of 120 hematologic and 120 solid tumor oncologists at MD Anderson Heme docs more likely to: Favor systemic therapy with moderate toxicity and no survival benefit Have a sense of failure with dz progression Heme docs less comfortable discussing: death and dying Hospice referral Hui D, et al. Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists. The Oncologist,
46 The Doctors are Different 3 tertiary centers w/ established PC programs Surveys and semi-structured interviews to better understand barriers to PC referral 66 interviewees; 23 heme, 43 solid tumor Most blood cancer specialists viewed palliative care as just end-of-life care, or hospice Frequent concerns about philosophical issues: non-palliative goals, not wanting another clinician to intrude on the patient-doctor relationship, etc. LeBlanc TW, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. Journal of Oncology Practice,
47 Hospice Doesn t Work for Us National survey study of 349 hematologic oncologists Key messages: Hospice care is helpful overall (68.1%) Home hospice care is inadequate for blood cancer patients needs (46%) >50% said they would be more likely to refer patients to hospice if transfusions were more available Odejide O, et al. Cancer, 2017.
48 LeBlanc and El-Jawahri. ASH Education Book,
49 DOES PALLIATIVE CARE WORK IN HEMATOLOGY? 52
50 Yoong JAMA IM 17(34) 2013
51 Different Focus Patients talk about different things with their oncologist than they do with their palliative care specialist Three primary foci of palliative care visits in oncology: 1. Symptom management 2. Engaging patients in emotional work 3. Serving as communication bridge Back AL, et al. Clinician roles in early integrated palliative care for patients with advanced cancer: a qualitative study. Journal of Palliative Medicine,
52 Unmet Symptom Needs in Hematologic Malignancies 50% 33% 36% 41% Heme-Malignancy Metastatic Solid Cancer Feeling nervous Irritable Feeling sad Feeling worried Manitta V, et al. The symptom burden of patients with hematological malignancy: a cross-sectional observational study. JPSM 2011.
53 Symptom Burden Manitta V, et al. The symptom burden of patients with hematological malignancy: a cross-sectional observational study. JPSM
Palliative Care for the Hematology Patient
Palliative Care for the Hematology Patient Thomas W. LeBlanc, MD, MA, MHS, FAAHPM Associate Professor of Medicine Division of Hematologic Malignancies Director, Cancer Patient Experience Research Program
More informationPALLIATIVE CARE IN HEMATOLOGIC MALIGNANCIES KEDAR KIRTANE MD FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON
PALLIATIVE CARE IN HEMATOLOGIC MALIGNANCIES KEDAR KIRTANE MD FRED HUTCHINSON CANCER RESEARCH CENTER UNIVERSITY OF WASHINGTON DISCLOSURES OBJECTIVES To discuss how hematologic malignancies qualitatively
More informationIntegrating Palliative and Oncology Care in Patients with Advanced Cancer
Integrating Palliative and Oncology Care in Patients with Advanced Cancer Jennifer Temel, MD Massachusetts General Hospital Cancer Center Director, Cancer Outcomes Research Overview 1. Why should we be
More informationPalliative Care in the Continuum of Oncologic Management
Palliative Care in the Continuum of Oncologic Management PC in the Routine Continuum of Cancer Care Michael W. Rabow, MD Director, Symptom Management Service Helen Diller Family Comprehensive Cancer Center
More informationQuality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study
Quality of End-of-Life Care in Patients with Hematologic Malignancies: A Retrospective Cohort Study David Hui, Neha Didwaniya, Marieberta Vidal, Seong Hoon Shin, Gary Chisholm, Joyce Roquemore, Eduardo
More informationPalliative Care & Haematology: Known Unknowns or Unknown Unknowns? Working towards a better collaboration.
Palliative Care & Haematology: Known Unknowns or Unknown Unknowns? Working towards a better collaboration. Dr Michelle Gold Director, Palliative Care Alfred Health ANZSPM Update June 2013 % Epidemiology
More information2012 AAHPM & HPNA Annual Assembly
in the Last 2 Weeks of Life: When is it Appropriate? When is it Not Appropriate? Disclosure No relevant financial relationships to disclose AAHPM SIG Presentation Participants Eric Prommer, MD, FAAHPM
More informationTHE ROLE OF PALLIATIVE CARE IN TREATMENT OF PATIENTS WITH CHRONIC, INFECTIOUS DISEASE
THE ROLE OF PALLIATIVE CARE IN TREATMENT OF PATIENTS WITH CHRONIC, INFECTIOUS DISEASE JESSICA MCFARLIN MD ASSISTANT PROFESSOR OF NEUROLOGY DIVISION CHIEF, PALLIATIVE AND SUPPORTIVE CARE I HAVE NO COI OR
More informationPalliative Care The Benefits of Early Intervention
The Royal Marsden Palliative Care The Benefits of Early Intervention Dr Anna-Marie Stevens, Nurse Consultant Symptom Control and Palliative Care Team, The Royal Marsden NHS Foundation Trust, London, UK
More informationIntegration of Palliative Care into Standard Oncology Care. Esther J. Luo MD Silicon Valley ONS June 2, 2018
Integration of Palliative Care into Standard Oncology Care Esther J. Luo MD Silicon Valley ONS June 2, 2018 Objectives Become familiar with the literature illustrating the benefits of palliative care in
More informationObjectives 4/20/2018. Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer. Outpatient Consultation Service
Function 4/20/2018 Complex Illness Support Alongside Standard Oncology Care for Patients with Incurable Cancer Kim Bland, DNP, APRN-NP, FNP, AOCN Objectives Discuss Complex Illness Support Review rationale
More informationTop 3 Tips in Decision Making
Top 3 Tips in Decision Making Jeanie Youngwerth, MD, FAAHPM University of Colorado School of Medicine Assistant Professor of Medicine, Hospitalist Associate Program Director, Colorado Palliative Medicine
More informationAdvances in Palliative Care
Steven Pantilat, MD Professor of Clinical Medicine Alan M. Kates and John M. Burnard Endowed Chair in Palliative Care Director, Palliative Care Program and Palliative Care Leadership Center Division of
More informationPalliative Care In PICU
Palliative Care In PICU Professor Lucy Lum University Malaya Annual Scientific Meeting on Intensive Care 15 August 2015 2 Defining Palliative Care: Mistaken perception: For patients whom curative care
More informationPreventing harmful treatment
Preventing harmful treatment How can Palliative Care prevent patients receiving overzealous or futile treatment? Antwerp, November 2010 Prof Scott A Murray, St Columba s Hospice Chair of Primary Palliative
More informationPalliative Care for Older Adults in the United States
Palliative Care for Older Adults in the United States Nathan Goldstein, MD Associate Professor Hertzberg Palliative Care Institute Brookdale Department of Geriatrics and Palliative Medicine Icahn School
More informationFinancial Disclosure. Learning Objectives. Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care
Evaluation of Chemotherapy in Last 2 Weeks of Life: CAMC Patterns of Care Steven J. Jubelirer, MD Clinical Professor Medicine WVU Charleston Division Senior Research Scientist CAMC Research Institute Charleston
More informationRelationship Building as a Component of Establishing Continuity of Care in Outpatient Palliative Care Program
Relationship Building as a Component of Establishing Continuity of Care in Outpatient Palliative Care Program Dory Hottensen, LCSW Social Work Supervisor New York Presbyterian Hospital-Weill Cornell Medical
More informationpatient decision aid advanced lung cancer
patient decision aid advanced lung cancer Introduction This aid is meant to supplement conversations with your care team. Patients who have used a decision aid like this said it helped them make care choices
More informationThe aggressiveness of cancer care near the end of life: Is it a quality of care issue?
The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute
More informationThe aggressiveness of cancer care near the end of life: Is it a quality of care issue?
The aggressiveness of cancer care near the end of life: Is it a quality of care issue? Craig Earle, MD MSc FRCPC Director, Health Services Research Program for Cancer Care Ontario & the Ontario Institute
More informationQuality of Life at the End of Life:
Quality of Life at the End of Life: Evaluating the Clinical Utility of the QUAL-EC in Patients with Advanced Cancer 13 th Australian Palliative Care Conference 2015 Melbourne, Australia October 1 st 4
More informationUsing The Serious Illness Conversation Guide
Using The Serious Illness Conversation Guide Anna C Beck, MD Associate Professor Director, Supportive Oncology & Survivorship Huntsman Cancer Institute Objectives Attitudes Reflect on the impact of communication
More informationIncreasing Access to Hospice Care for African Americans in the Carolinas: Lessons Learned from Hospice Providers. Objectives 9/9/2015
Increasing Access to Hospice Care for African Americans in the Carolinas: Kimberly S. Johnson MD MHS Division of Geriatrics, Center for Aging Duke Palliative Care Duke University Medical Center GRECC,
More informationIdentify essential primary palliative care (PPC) communication skills that every provider needs AND clinical triggers for PPC conversations
Identify essential primary palliative care (PPC) communication skills that every provider needs AND clinical triggers for PPC conversations Esmé Finlay, MD Division of Palliative Medicine University of
More informationAccurate prognostic awareness facilitates, whereas better quality of life and more anxiety symptoms hinder end-of-life discussions
Accurate prognostic awareness facilitates, whereas better quality of life and more anxiety symptoms hinder end-of-life discussions Siew Tzuh Tang, DNSc Chang Gung University, School of Nursing Importance
More informationWHAT FACTORS INFLUENCE AN ANALYSIS OF HOSPITALIZATIONS AMONG DYING CANCER PATIENTS? AGGRESSIVE END-OF-LIFE CANCER CARE. Deesha Patel May 11, 2011
WHAT FACTORS INFLUENCE HOSPITALIZATIONS AMONG DYING CANCER PATIENTS? AN ANALYSIS OF AGGRESSIVE END-OF-LIFE CANCER CARE. Deesha Patel May 11, 2011 WHAT IS AGGRESSIVE EOL CARE? Use of ineffective medical
More information12/6/2016. Objective PALLIATIVE CARE IN THE NURSING HOME. Medical Care in the US. Palliative Care
Objective PALLIATIVE CARE IN THE NURSING HOME Deborah Morris, M.D., M.H.S. Assistant Professor of Medicine The Glennan Center for Geriatrics and Gerontology Eastern Virginia Medical School Describe program
More informationAuthor Block M. Fisch, J. W. Lee, J. Manola, L. Wagner, V. Chang, P. Gilman, K. Lear, L. Baez, C. Cleeland University of Texas M.D. Anderson Cancer Ce
Survey of disease and treatment-related t t related symptoms in outpatients with invasive i cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study, Abst # 9619) Michael J. Fisch,
More informationWellness along the Cancer Journey: Palliative Care Revised October 2015
Wellness along the Cancer Journey: Palliative Care Revised October 2015 Chapter 2: Palliative Care Palliative Care Rev. 10.8.15 Page 352 Group Discussion True False Not Sure 1. Palliative care is only
More informationNext, I m going to ask you to read several statements. After you read each statement, circle the number that best represents how you feel.
Participant ID: Interviewer: Date: / / The [clinic name], Devers Eye Institute, and the Northwest Portland Area Indian Health Board are doing a survey about beliefs and behaviors related to eye health
More informationUnderstanding referrals to outpatient palliative care and goals of care discussions with individuals diagnosed with stage IV advanced cancer
Understanding referrals to outpatient palliative care and goals of care discussions with individuals diagnosed with stage IV advanced cancer ELLIS DILLON, JINNAN LI, AMY MEEHAN, SU-YING LIANG, STEVE LAI,
More informationSingle Technology Appraisal (STA) Midostaurin for untreated acute myeloid leukaemia
Single Technology Appraisal (STA) Midostaurin for untreated acute myeloid leukaemia Response to consultee and commentator comments on the draft remit and draft scope (pre-referral) Please note: Comments
More informationDeprescribing. Deprescribing. Webinar #12 Webinar #1 Developing Cultural Competency. Addressing EOL Issues Jessica Visco, PharmD, CGP
August 24, 2016 Webinar #12 Webinar #1 Developing Cultural Competency in Deprescribing Addressing EOL Issues Jessica Visco, PharmD, CGP SeniorPharmAssist Kimberly S. Johnson MD MHS Associate Professor
More informationAchieving earlier entry to hospice care: Issues and strategies. Sonia Lee, APN, GCNS-BC
Achieving earlier entry to hospice care: Issues and strategies Sonia Lee, APN, GCNS-BC Objectives The learner will: Describe the benefits of hospice List at least barriers to early hospice care List at
More informationInnovation in Physician Payment and Organization for Cancer Care. Jennifer Malin, MD, PhD Medical Director, Oncology
Innovation in Physician Payment and Organization for Cancer Care Jennifer Malin, MD, PhD Medical Director, Oncology Current Oncology Care Model Unsustainable High Cost & Trend U.S. spending on cancer increased
More informationPalliative Care: Expanding the Role Throughout the Patient s Journey. Dr. Robert Sauls Regional Lead for Palliative Care
Palliative Care: Expanding the Role Throughout the Patient s Journey Dr. Robert Sauls Regional Lead for Palliative Care 1 Faculty/Presenter Disclosure Faculty: Dr. Robert Sauls MD, with the Mississauga
More informationdemonstrate the principles of effective communication when interacting with people with lifelimiting
MODULE 2 Communicating with people with life-limiting illnesses Providing support for people with life-limiting illnesses requires you to understand the meaning of the illness and its effects on individuals.
More informationSymptoms Assess symptoms and needs across all domains. Screen using Edmonton Symptom Assessment System (ESAS) for: Pain Nausea Depression
A Palliative Care Approach for Oncology Integrating a palliative care approach earlier in the disease trajectory improves the quality of living and dying, and relieves suffering for patients and families
More informationA Practical Approach to Palliative Care in the ICU
A Practical Approach to Palliative Care in the ICU Wendy Anderson, MD MS Critical Care Medicine and Trauma May 31, 2013 Disclosure Statement Dr. Anderson has no relevant financial relationships to disclose.
More informationQuality and Fiscal Metrics: What Proves Success?
Quality and Fiscal Metrics: What Proves Success? 1 Quality and Fiscal Metrics: What Proves Success? Kathleen Kerr Kerr Healthcare Analytics Creating the Future of Palliative Care NHPCO Virtual Event February
More informationDr Mhoira Leng, Makerere Palliative Care Unit
Dr Mhoira Leng, Makerere Palliative Care Unit End-of-Life Chemotherapy and Palliative Referrals at the Uganda Cancer Institute. Daniel Low, Elizabeth Namukwaya, Henry Ddungu, Mhoira Leng Background Early
More informationStuart Murdoch Consultant Intensive Care St. James s University Hospital March 2010
Stuart Murdoch Consultant Intensive Care St. James s University Hospital March 2010 Background- Critical Care Critical Care originated in Denmark with Polio epidemic 1950s respiratory support alone Rapid
More informationEarly Integration of Palliative Care
Early Integration of Palliative Care Dr. Camilla Zimmermann Head, Palliative Care Program University Health Network Toronto November 1, 2014 www.fpon.ca Early Integration of Palliative Care: Evidence and
More informationJonathan W Friedberg, MD, MMSc
I N T E R V I E W Jonathan W Friedberg, MD, MMSc Dr Friedberg is Professor of Medicine and Oncology and Chief of the Hematology/Oncology Division at the University of Rochester s James P Wilmot Cancer
More informationTransitioning to palliative care: How early is early palliative care?
Transitioning to palliative care: How early is early palliative care? Cancer: a growing problem Cancer is an increasing health care problem It is estimated that by 2020, there will be 20 million new cases
More informationDelivering Bad News. April 27, 2017
Delivering Bad News April 27, 2017 Introduction Barbara Lewis, MBA Managing Editor DocCom Timothy E. Quill, MD, FACP, FAAHPM Distinguished Professor of Medicine Palliative Care Program University of Rochester
More informationNovember Webinar Journal Club Aims. Session 2: Spiritual Screening - Using Just One Question
Session 2: Spiritual Screening - Using Just One Question APC Webinar Journal Club http://www.professionalchaplains.org/apcstore/productdetails.aspx?productid=apcwebwjc Webinar Journal Club Aims Substantive
More informationPALLIATIVE CARE PALLIATIVE CARE FOR THE CANCER PATIENT OBJECTIVES. Mountain States Cancer Conference November 2, 2013
PALLIATIVE CARE FOR THE CANCER PATIENT Mountain States Cancer Conference November 2, 2013 Jean S. Kutner, MD, MSPH Gordon Meiklejohn Endowed Professor of Medicine OBJECTIVES To apply evidence regarding
More informationTalking to Your Oncologist & Living with Cancer
Talking to Your Oncologist & Living with Cancer Anthony Back, M.D. University of Washington Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Highlights? The old way doctors talked What
More informationEarly Supportive/Palliative Care Intervention in Lung Cancer. Ashique Ahamed Central Manchester University Hospitals NHS Foundation Trust
Early Supportive/Palliative Care Intervention in Lung Cancer Ashique Ahamed Central Manchester University Hospitals NHS Foundation Trust Outline Lung Cancer Incidence Symptom burden in Lung Cancer Evidence
More informationFamilies Confronting the End-of-Life: Promoting Peaceful Acceptance of Death
Families Confronting the End-of-Life: Promoting Peaceful Acceptance of Death Holly G. Prigerson, PhD Director, Center for Psycho-oncology & Palliative Care Research Dana-Farber Cancer Institute Associate
More informationThe Changing Face of MDS: Advances in Treatment
Thank you very much again for listening to me. We are going to be talking now in terms of therapy of MDS or The Changing Face of MDS Advances in Treatment. My name is Guillermo Garcia-Manero. I am a Professor
More informationOverview of Some Cultural Considerations
Overview of Some Cultural Considerations Mark Lazenby PhD FAAN Associate Professor of Nursing, Divinity, & Middle East Studies The Term Culture The ideas, customs, and social behavior of a particular people
More informationPalliative Care in the ED:
Palliative Care in the ED: Don t Just Do Something Stand There Eric Isaacs, MD, FACEP Attending Physician, San Francisco General Hospital and Trauma Center Professor of Emergency Medicine, University of
More informationA Population Health Approach to Palliative Care
A Population Health Approach to Palliative Care Steven Pantilat, MD Professor of Medicine Kates-Burnard and Hellman Distinguished Professor in Palliative Care Director, and Palliative Care Quality Network
More informationQuality ID #457 (NQF 0216): Proportion Admitted to Hospice for less than 3 days- National Quality Strategy Domain: Effective Clinical Care
Quality ID #457 (NQF 0216): Proportion Admitted to Hospice for less than 3 days- National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationChanging the Face of Palliative Care in Oncology Practice
Changing the Face of Palliative Care in Oncology Practice Karin Porter-Williamson MD Associate Professor of Medicine Medical Director Palliative Care Services KU Hospital Amy Velasquez RN BSN OCN Allen
More informationThe Integration of Palliative Care into Standard Oncology Care. American Society of Clinical Oncology Provisional Clinical Opinion
The Integration of Palliative Care into Standard Oncology Care American Society of Clinical Oncology Provisional Clinical Opinion The Provisional Clinical Opinion Based on strong evidence from a phase
More informationCommunicating with Patients with Heart Failure and their Families
Communicating with Patients with Heart Failure and their Families Nathan Goldstein, MD Associate Professor Hertzberg Palliative Care Institute Brookdale Department of Geriatrics and Palliative Medicine
More informationSupportive Care For Hematological Malignancies
Supportive Care For Hematological Malignancies Nawaf Alkhayat, MD Pediatric Hematology, Oncology & BMT Prince Sultan Military Medical City Riyadh, KSA Supportive care Definition Why we need supportive
More information9/19/2017. Population-Based Palliative Care: The Next Phase of Clinical Care, Education, and Research. Population-Based Palliative Care JR:
Population-Based Palliative Care: The Next Phase of Clinical Care, Education, and Research David Casarett, MD, MA Chief of Palliative Care Professor of Medicine Duke University/Duke Health Population-Based
More information7/24/2017. MDS: Understanding Your Diagnosis and Current and Emerging Treatments. Hematopoiesis = Blood Cell Production
: Understanding Your Diagnosis and Current and Emerging Treatments Erica Warlick, MD Associate Professor of Medicine Division of Hematology, Oncology, and Transplantation University of MN Objectives Overview
More informationSymptom Assessment. Jo Thompson Lead Nurse Supportive & Palliative Care Royal Surrey County Hospital, Guildford
Symptom Assessment Jo Thompson Lead Nurse Supportive & Palliative Care Royal Surrey County Hospital, Guildford Aims Highlight the evidence for thorough symptom assessment Discuss the pros and cons of using
More informationPalliative Care Impact on Patients with Breast Cancer. Sigy Chathanatt, D.O. Board Certified in Hospice and Palliative Care September 17, 2016
Palliative Care Impact on Patients with Breast Cancer Sigy Chathanatt, D.O. Board Certified in Hospice and Palliative Care September 17, 2016 What do We Know? Cancer as a Disease Experience Survival rates
More informationPalliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities
Palliative Care in Adolescents and Young Adults Needs, Obstacles and Opportunities Justin N Baker, MD, FAAP, FAAHPM Chief, Division of Quality of Life and Palliative Care Attending Physician, Quality of
More informationInaugural Guildford Supportive Care in Cancer Course
Inaugural Guildford Supportive Care in Cancer Course SUPPORTIVE CARE OVERVIEW Declan Walsh 4 th November 2015 A BRIEF HISTORY OF MEDICINE 2000 BC HERE, EAT THIS ROOT 1000 AD THAT ROOT IS HEATHEN, SAY THIS
More informationLiving with Advanced Colorectal Cancer: A Balancing Act
Living with Advanced Colorectal Cancer: A Balancing Act Simone Stenekes Clinical Nurse Specialist CancerCare Manitoba Symptom Management & Palliative Care Disease Site Group Presenter Disclosure Faculty:
More informationHIGHLIGHTS ESMO 2017 SUPPORTIVE AND PALLIATIVE CARE
HIGHLIGHTS ESMO 2017 SUPPORTIVE AND PALLIATIVE CARE Florian Scotté MD-PhD Hôpital Foch, Suresnes, France esmo.org DISCLOSURE SLIDE Consultant / Advisory Boards / Speaker: Tesaro, Sanofi, Roche, MSD, TEVA,
More informationHow Long Do I Have? The Art and Science of Prognostication
How Long Do I Have? The Art and Science of Prognostication Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Associate Program Director, Colorado
More informationPalliative Care: Mission and Strategic Imperative. Sarah E. Hetue Hill, PhD Ascension Healthcare
Palliative Care: Mission and Strategic Imperative Sarah E. Hetue Hill, PhD Ascension Healthcare Ascension Palliative Care Definition Palliative Care is person-centered, holistic care delivered by an interdisciplinary
More informationPatient s dilemma. Hospice Care. Benefits of Palliative Care? The reflections and the development of palliative care service a physician s perspective
0th HK Palliative Care Symposium The reflections and the development of palliative care service a physician s perspective Dr KS Chan Haven of Hope Hospital 0th Hong Kong Palliative Care symposium 203 Benefits
More informationHow hematologists perceive critical care- Acute myeloid leukemia
How hematologists perceive critical care- Acute myeloid leukemia Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Research Meeting June 30 th 2011 Peter Schellongowski Intensive Care
More informationText-based Document. Pain Management and Palliative Care: A Program of Research. Huijer, Huda Abu-Saad. Downloaded 9-May :53:16
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationI have no financial disclosures.
Palliative Medicine: Year(s) in Review I have no financial disclosures. Lynn A Flint, MD Staff Physician, SFVAMC Assistant Clinical Professor Division of Geriatrics Advances in Internal Medicine 2012 2
More informationPalliative Care Pearls: What Works, What Doesn t
: Steven Pantilat, MD Kates-Burnard and Hellman Distinguished Professor of Palliative Care Director, Palliative Care Program and Palliative Care Quality Network Department of Medicine University of California,
More informationThe Cost of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of Decedents at a Comprehensive Cancer Center
The Cost of Waiting: Implications of the Timing of Palliative Care Consultation among a Cohort of Decedents at a Comprehensive Cancer Center PCQN Group Discussion, March 12, 2015 Colin Scibetta, MD Clinical
More informationDeath as Great Equalizer? Recognizing & Reducing Disparities in End-Stage Cancer Care
Death as Great Equalizer? Recognizing & Reducing Disparities in End-Stage Cancer Care Holly G. Prigerson, PhD Irving Sherwood Wright Professor of Geriatrics Professor of Sociology in Medicine Director,
More informationUsing claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center
Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.
More informationIntegration of Palliative and Oncology Care in patients with lung and other
1 Integration of Palliative and Oncology Care in patients with lung and other thoracic cancer: referral criteria and clinical care pathways. A. Caraceni, C. Brunelli, S. Lo Dico, E. Zecca, P. Bracchi,
More informationPalliative Care in the ICU
Palliative Care in the ICU David M. Fedor, DO, FACP, HMDC Intermountain Health Care Physician Intensivist-Critical Care Medicine: MckayDee Hospital; Medical Director - Palliative Care at Mckay Dee Hospital;
More informationCommunicating Title with Your Healthcare Team to Get the Care You Want. Click to edit Master text styles
Communicating Title with Your Healthcare Team to Get the Care You Want Click to edit Master text styles Lori Ranallo, Title RN, MSN, ARNP-BC, CBCN Click to edit Master text styles Breast Cancer Nurse Practitioner
More informationMaintaining Long-Term Efficacy in the Elderly MDS Patient with Poor Performance Status
Hi, my name is Dr. Hetty Carraway. I am a staff physician at the Taussig Cancer Institute at the Cleveland Clinic. Welcome to Managing MDS. 1 As you all are aware, many of our patients with MDS are in
More informationLymphoma in Dogs What You Need to Know
Lymphoma in Dogs What You Need to Know The word cancer elicits many different feelings for people fear, helplessness, and uncertainty just to name a few. Sadly, our fur babies aren t immune from the grips
More informationOregon Health Plan Guideline Note 12
Oregon Health Plan Guideline Note 12 How do we implement cost effective cancer treatment in patients with short life expectancy with a limited budget? November 16, 2013 Kevin Olson MD History of Medicaid
More informationEasing the transition from curative care to palliative care
Easing the transition from curative care to palliative care Manon Coulombe, RN, MSc(A), CHPCN(C) Pivot nurse in palliative care mcoulombe2.hmr@ssss.gouv.qc.ca Presentation My clinical practice Characteristics
More informationThe Role of Palliative Care in Readmission Reduction Steven Z. Pantilat, MD
The Role of Palliative Care in Readmission Reduction Steven Z. Pantilat, MD Professor of Clinical Medicine Alan M. Kates and John M. Burnard Endowed Chair in Palliative Care Director, Palliative Care Program
More informationSUICIDE RISK IN PALLIATIVE/ EoL SETTINGS
SUICIDE RISK IN PALLIATIVE/ EoL SETTINGS M A R C K I N G S L S E Y C. P S Y C H O L C O N S U L T A N T C L I N I C A L P S Y C H O L O G I S T / P S Y C H O -ON C O L O GI S T SUICIDE RISK IN PALLIATIVE/
More informationPalliative Care in the Community
Palliative Care in the Community Carol Babcock, MFT Director Palliative Care, Navicent Health American College of Surgeons Commission on Cancer (CoC) Standard 2.4 Palliative care services are available
More informationAfter Soft Tissue Sarcoma Treatment
After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?
More informationPalliative Care: A Place on the Quality Scorecard?
Palliative Care: A Place on the Quality Scorecard? J. Randall Curtis, MD, MPH Professor of Medicine Director, Palliative Care Center of Excellence www.uwpalliativecarecenter.com Disclosures and Funding
More informationPalliative Care & Hospice
Palliative Care & Hospice Kenneth Brummel-Smith, M.D. Charlotte Edwards Maguire Professor, Department of Geriatrics Florida State University College of Medicine 1 Diane Meier, MD Director, Center to Advance
More informationEstimating and explaining survival time in metastatic breast cancer
Estimating and explaining survival time in metastatic breast cancer Dr Belinda Kiely Medical Oncologist Concord and Campbelltown Hospitals NHMRC Clinical Trials Centre, University of Sydney Clinic this
More informationPAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT
PAIN MANAGEMENT & MAXIMIZING QUALITY OF LIFE DURING TREATMENT Brandy Ficek, MD Medical Director of Quality of Life and Palliative Medicine Cancer Treatment Centers of America Rocky Mountain Blood Cancer
More informationRoad Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice.
Road Blocks in Non-Cancer Palliative Care Obstacles observed from outpatient non-cancer palliative practice. 25th Annual Palliative Education and Research Days, West Edmonton Mall. Edmonton. 2014 Amanda
More informationCorporate Medical Policy. Policy Effective February 23, 2018
Corporate Medical Policy Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_flt3_npm1_and_cebpa_mutations_in_acute_myeloid_leukemia
More informationDr. Andrea Johnson Saskatoon Health Region/Saskatoon Cancer Centre September 30, 2016
Dr. Andrea Johnson Saskatoon Health Region/Saskatoon Cancer Centre September 30, 2016 Conflicts of Interest None... Our drugs are old and cheap (for the most part) so big pharma isn t really interested
More informationDESIRE FOR DEATH, SELF HARM AND SUICIDE IN TERMINAL ILLNESS. Dr Annabel Price
DESIRE FOR DEATH, SELF HARM AND SUICIDE IN TERMINAL ILLNESS Dr Annabel Price Overview Risk of suicide and self harm in the terminally ill Desire for hastened death in the terminally ill Measurement Associations
More informationHospice and Palliative Care An Essential Component of the Aging Services Network
Hospice and Palliative Care An Essential Component of the Aging Services Network Howard Tuch, MD, MS American Academy of Hospice and Palliative Medicine Physician Advocate, American Academy of Hospice
More informationHematology/Oncology Inpatient Rotation (Gold) PL2 Residents
PL2 Residents The Gold team at Comer Children s Hospital at the University of Chicago is comprised of 4 residents who care exclusively for inpatients suffering from hematologic and oncologic conditions.
More information